Logitech devices are designed not just to work, but to work smarter, with added customization, comfort, and productivity-focused features. At its core, Logitech focuses on creating software-enabled ...
Setpoint’s acquisition of inTENT Fulfillment will add experienced leaders and broaden ratings agency approvals for its asset-backed finance platform. AI Summary Setpoint, an operating system for asset ...
Publication of 12-month outcomes reinforces SetPoint Medical’s pioneering role in advancing neuroimmune modulation as a new treatment paradigm for rheumatoid arthritis (RA) VALENCIA, Calif.--(BUSINESS ...
Follow this author to personalize your feed and get instant alerts. WHY FOLLOW? Custom Feed: See the stories that matter most to you. Smart Alerts: Get notified about major news as it happens. Update ...
For fixing Windows errors, we recommend Fortect: Fortect will identify and deploy the correct fix for your Windows errors. Follow the 3 easy steps to get rid of Windows errors: The Logitech Unifying ...
SetPoint Medical, a Valencia-based company dedicated to developing therapies for people living with chronic autoimmune diseases, raised $140 million in private financing that includes $25 million in ...
Fresh after getting the green light from the U.S. Food and Drug Administration, SetPoint Medical raises $140 million to market and distribute its rheumatoid arthritis treatment. SetPoint Medical Chief ...
The neuroimmune modulation therapy system is designed for individuals with moderate-to-severe rheumatoid arthritis. Credit: Chinnapong / Shutterstock.com. · Medical Device Network · Chinnapong / ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
SetPoint Medical has raised $140 million. This includes $25 million in the second tranche of its Series C financing, as well as $115 million in its Series D financing, co-led by Elevage Medical ...
The U.S. Food and Drug Administration has approved the SetPoint System, a neuroimmune modulation device for the treatment of adults living with moderate-to-severe rheumatoid arthritis (RA). The ...
The SetPoint System is indicated for patients who are not adequately managed by -- or cannot tolerate -- existing advanced RA therapies, such as biological and targeted synthetic disease-modifying ...